title: Photodynamic therapy for choroidal neovascular membrane secondary to optic nerve drusen.
abstract: The authors describe the use of photodynamic therapy with verteporfin for subfoveal choroidal neovascular membrane secondary to optic nerve drusen. A 28-year-old woman had a peripapillary choroidal neovascular membrane secondary to optic nerve drusen with significant metamorphopsia. Photodynamic therapy using verteporfin was performed. Visual acuity improved to 20/20 with resolution of metamorphopsia and absence of leakage on fluorescein angiography a few weeks after verteporfin therapy. The patient's condition remained stable for 16 months with 20/20 vision. Photodynamic therapy with verteporfin may be a useful treatment option in patients with choroidal neovascular membranes secondary to optic nerve drusen.
authors.affiliation: New England Retina Research and Education Foundation, Hamden, Connecticut, USA.
authors.forename: Nauman A
authors.initials: NA
authors.lastname: Chaudhry
authors.forename: Alejandro J
authors.initials: AJ
authors.lastname: Lavaque
authors.forename: Anish
authors.initials: A
authors.lastname: Shah
authors.forename: Peter E
authors.initials: PE
authors.lastname: Liggett
mesh_terms: D000328:Adult; D020256:Choroidal Neovascularization / Q000188:drug therapy* / Q000209:etiology*; D005260:Female; D005451:Fluorescein Angiography; D006801:Humans; D015594:Optic Disk Drusen / Q000150:complications*; D010778:Photochemotherapy; D017319:Photosensitizing Agents / Q000627:therapeutic use*; D011166:Porphyrins / Q000627:therapeutic use*; D016896:Treatment Outcome; D000077362:Verteporfin; D014792:Visual Acuity
chemical_list: D017319:Photosensitizing Agents; D011166:Porphyrins; D000077362:Verteporfin